Johnson & Johnson 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-27 11:12 am Sale |
2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
JOHNSON & JOHNSON JNJ |
3,670,516 8.200% |
-89,118 (-2.37%) |
Filing |
| 2020-07-02 6:21 pm Purchase |
2020-06-30 | 13G | Fusion Pharmaceuticals Inc. FUSN |
JOHNSON & JOHNSON JNJ |
3,759,634 9.000% |
3,759,634 (New Position) |
Filing |